Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

doi:10.1093/cid/ciu269

Comparative Study

. 2014 Jul 15;59(2):252-5.

doi: 10.1093/cid/ciu269. Epub 2014 Apr 18.

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

Su Su¹, Sandra S Chaves², Alejandro Perez², Tiffany D'Mello¹, Pam D Kirley³, Kimberly Yousey-Hindes⁴, Monica M Farley⁵, Meghan Harris⁶, Ruta Sharangpani⁷, Ruth Lynfield⁸, Craig Morin⁸, Emily B Hancock⁹, Shelley Zansky¹⁰, Gary E Hollick¹¹, Brian Fowler¹², Christie McDonald-Hamm¹³, Ann Thomas¹⁴, Vickie Horan¹⁵, Mary Lou Lindegren¹⁶, William Schaffner¹⁶, Andrea Price¹⁷, Ananda Bandyopadhyay¹⁸, Alicia M Fry²

Affiliations

¹ Influenza Division, Centers for Disease Control and Prevention Atlanta Research and Education Foundation, Atlanta, Georgia.
² Influenza Division, Centers for Disease Control and Prevention.
³ California Emerging Infections Program, Oakland.
⁴ Connecticut Emerging Infectious Program, Yale University, New Haven, Connecticut.
⁵ School of Medicine, Emory University, and Atlanta Veterans Affairs Medical Center, Atlanta, GA.
⁶ Iowa Department of Public Health, Des Moines.
⁷ Michigan Department of Community Health, Lansing.
⁸ Minnesota Department of Health, St. Paul.
⁹ New Mexico Department of Health, Santa Fe.
¹⁰ Emerging Infections Program, New York State Department of Health, Albany.
¹¹ Department of Medicine, University of Rochester School of Medicine and Dentistry, New York.
¹² Ohio Department of Health, Columbus.
¹³ Oklahoma State Department of Health, Oklahoma City.
¹⁴ Oregon Public Health Division, Portland.
¹⁵ South Dakota Department of Health, Pierre.
¹⁶ Vanderbilt University School of Medicine, Nashville, Tennessee.
¹⁷ Salt Lake County Health Department, Salt Lake City, Utah.
¹⁸ The Bill & Melinda Gates Foundation, Seattle, Washington.

PMID: 24748521
DOI: 10.1093/cid/ciu269

Comparative Study

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

Su Su et al. Clin Infect Dis. 2014.

. 2014 Jul 15;59(2):252-5.

doi: 10.1093/cid/ciu269. Epub 2014 Apr 18.

Authors

Affiliations

¹ Influenza Division, Centers for Disease Control and Prevention Atlanta Research and Education Foundation, Atlanta, Georgia.
² Influenza Division, Centers for Disease Control and Prevention.
³ California Emerging Infections Program, Oakland.
⁴ Connecticut Emerging Infectious Program, Yale University, New Haven, Connecticut.
⁵ School of Medicine, Emory University, and Atlanta Veterans Affairs Medical Center, Atlanta, GA.
⁶ Iowa Department of Public Health, Des Moines.
⁷ Michigan Department of Community Health, Lansing.
⁸ Minnesota Department of Health, St. Paul.
⁹ New Mexico Department of Health, Santa Fe.
¹⁰ Emerging Infections Program, New York State Department of Health, Albany.
¹¹ Department of Medicine, University of Rochester School of Medicine and Dentistry, New York.
¹² Ohio Department of Health, Columbus.
¹³ Oklahoma State Department of Health, Oklahoma City.
¹⁴ Oregon Public Health Division, Portland.
¹⁵ South Dakota Department of Health, Pierre.
¹⁶ Vanderbilt University School of Medicine, Nashville, Tennessee.
¹⁷ Salt Lake County Health Department, Salt Lake City, Utah.
¹⁸ The Bill & Melinda Gates Foundation, Seattle, Washington.

PMID: 24748521
DOI: 10.1093/cid/ciu269

Abstract

We challenge the notion that influenza B is milder than influenza A by finding similar clinical characteristics between hospitalized adult influenza-cases. Among patients treated with oseltamivir, length of stay and mortality did not differ by type of virus infection.

Keywords: adult; antiviral treatment; hospitalization; influenza A and B virus infection.

Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

PubMed Disclaimer

Cited by

Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function.
Dumm RE, Fiege JK, Waring BM, Kuo CT, Langlois RA, Heaton NS. Dumm RE, et al. Nat Commun. 2019 Feb 15;10(1):779. doi: 10.1038/s41467-019-08617-z. Nat Commun. 2019. PMID: 30770807 Free PMC article.
The burden of laboratory-confirmed influenza infection in Lebanon between 2008 and 2016: a single tertiary care center experience.
Assaf-Casals A, Saleh Z, Khafaja S, Fayad D, Ezzeddine H, Saleh M, Chamseddine S, Sayegh R, Sharara SL, Chmaisse A, Kanj SS, Kanafani Z, Hanna-Wakim R, Araj GF, Mahfouz R, Saito R, Suzuki H, Zaraket H, Dbaibo GS. Assaf-Casals A, et al. BMC Infect Dis. 2020 May 12;20(1):339. doi: 10.1186/s12879-020-05013-7. BMC Infect Dis. 2020. PMID: 32397965 Free PMC article.
Learning in times of stress: Lessons from COVID-19 that will last throughout this century.
Jiménez-Fonseca P, Salazar R, Valentí V, Carmona-Bayonas A, Agnelli G. Jiménez-Fonseca P, et al. Eur J Intern Med. 2022 Feb;96:1-4. doi: 10.1016/j.ejim.2021.11.002. Epub 2021 Nov 12. Eur J Intern Med. 2022. PMID: 34801401 Free PMC article.
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.
Patel MC, Shirey KA, Boukhvalova MS, Vogel SN, Blanco JCG. Patel MC, et al. mBio. 2018 Mar 13;9(2):e00246-18. doi: 10.1128/mBio.00246-18. mBio. 2018. PMID: 29535197 Free PMC article.
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice.
Liu Y, Strohmeier S, González-Domínguez I, Tan J, Simon V, Krammer F, García-Sastre A, Palese P, Sun W. Liu Y, et al. Front Immunol. 2021 Sep 16;12:746447. doi: 10.3389/fimmu.2021.746447. eCollection 2021. Front Immunol. 2021. PMID: 34603333 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

5U38HM000414/HM/NCHM CDC HHS/United States

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

Affiliations

Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical